Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivmecillinam Hydrochloride Tablets Versus Fosfomycin Tromethamine Granules for Uncomplicated Urinary Tract Infection in Women -A Randomized, Double-blind, Double Simulation, Positive Drug Parallel-controlled, Multi Center Phase III Clinical Trial in China

NCT05545137 is registered in ClinicalTrials.gov with Benova (Tianjin) Innovative medicine Research Co., Ltd. as lead sponsor.

NCT NCT05545137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05545137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivmecillinam Hydrochloride Tablets Versus Fosfomycin Tromethamine Granules for Uncomplicated Urinary Tract Infection in Women -A Randomized, Double-blind, Double Simulation, Positive Drug Parallel-controlled, Multi Center Phase III Clinical Trial in China
Lead sponsor
Benova (Tianjin) Innovative medicine Research Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 29, 2022
Completion date
February 20, 2024
Enrollment
299 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

uncomplicated urinary tract infection